EULAR心血管风险管理指南在类风湿关节炎中的实施:初级与二级医疗成功协作的结果
该观点文章首先概述文献显示类风湿关节炎(RA)患者的心血管疾病危险因素(CVD-RF)筛查在初级和二级医疗中均应用不足。随后描述荷兰南部地区风湿科医生与全科医生(GP)紧密协作实施EULAR心血管疾病风险管理(CVRM)指南的案例,以血脂谱作为既往5年内是否进行CVD-RF筛查的指标。在628例RA患者中,72%(n=454)既往5年内测定了血脂谱;作为常规质量控制的一部分,对未筛查的RA患者向GP发送提醒信后,88%的RA患者完成了CVD风险评估。
要点
- EULAR指南推荐所有RA患者至少每5年进行一次CVD风险评估。
- 文献显示RA患者的CVD-RF筛查在初级和二级医疗中均应用不足。
- 荷兰南部协作以血脂谱为指标,提醒信后88%的RA患者完成CVD风险评估。
核心结论
- 风湿科医生与全科医生协作并辅以提醒系统,可有效实施EULAR心血管风险管理指南。
- 该协作模式可作为遵循EULAR指南提供医疗服务的良好实践。
研究设计与样本
- 本文为观点文章,先文献概述RA患者CVD-RF筛查的研究,再描述荷兰南部地区初级与二级医疗协作实施EULAR CVRM指南的案例。
主要发现
- 文献概述表明RA患者的CVD-RF筛查在初级和二级医疗中均仅边缘化应用。
- 在628例RA患者中,72%(n=454)既往5年内测定了血脂谱。
- 发送提醒信后,88%的RA患者完成了CVD风险评估。
关键数值与推荐
- EULAR指南推荐所有RA患者至少每5年进行一次CVD风险评估。
- 协作中以血脂谱作为评估既往5年内是否进行CVD-RF筛查的指标。
- 作为常规质量控制,对未筛查的RA患者向全科医生发送提醒信。
临床怎么用
- 风湿科与全科医生应建立协作机制,明确初级和二级医疗专业人员的职责。
- 可以血脂谱作为CVD-RF筛查的质控指标,并对未筛查患者发送提醒以提高筛查率。
局限性
- 本文为观点文章,所述协作案例来自荷兰南部一个地区,未报告对照设计或普遍适用性评估。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The updated European League Against Rheumatism (EULAR) guideline recommends cardiovascular disease (CVD) risk assessment at least once every 5 years in all patients with rheumatoid arthritis (RA). This viewpoint starts with a literature overview of studies that investigated the level of CVD risk factor (CVD-RF) screening in patients with RA in general practices or in outpatient clinics. These studies indicate that CVD-RF screening in patients with RA is marginally applied in clinical practice, in primary as well as secondary care. Therefore, the second part of this viewpoint describes an example of the successful implementation of the EULAR cardiovascular disease risk management (CVRM) guideline in patients with RA in a region in the south of the Netherlands where rheumatologists and general practitioners (GPs) closely collaborate to manage the cardiovascular risk of patients with RA. The different components of this collaboration and the responsibilities of respectively primary and secondary care professionals are described. Within this collaboration, lipid profile was used as an indicator to assess whether CVD-RF screening was performed in the previous 5 years. In 72% (n=454) of the 628 patients with RA, a lipid profile was determined in the previous 5 years. As part of routine quality control, a reminder was sent to the GP in case a patient with RA was not screened. After sending the reminder letter, in 88% of all patients with RA, CVD risk assessment was performed. This collaboration can be seen as good practice to provide care in line with the EULAR guideline.
引用
- Weijers JM, Rongen-van Dartel SAA, Hoevenaars DMGMF, et al. Implementation of the EULAR cardiovascular risk management guideline in patients with rheumatoid arthritis: results of a successful collaboration between primary and secondary care. Ann Rheum Dis. 2017. PMID: 29167154. doi:10.1136/annrheumdis-2017-212392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。